Engelsk

This sample attributes table includes body site where sample was collected, analyte type, tumor status, and sequencing center.

9 Formulär  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table includes subject IDs, consent information, and subject aliases.
    3. This pedigree data table contains family relationships in the format of family IDs, subject IDs, father IDs, mother IDs, subjects's sex, and family group ethnicity.
    4. This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
    5. Family Subject Phenotypes (WGS) year 1: AD affection status, Braak stage, presence of APOE allele combinations, availability of autopsy material, and general sociodemographic (race and ethnicity) data of participants for whom whole genome sequencing (WGS) data are available.
    6. This sample attributes table includes body site where sample was collected, analyte type, tumor status, and sequencing center.
    7. Connecting Family Subject Phenotypes year 1: participants' family members' AD affection status, Braak stage, APOE allele presence, availability of autopsy material, and general sociodemographic data (race and ethnicity).
    8. Case Control Enriched Phenotypes (WES) year 0: prevalent and incident AD status, AD diagnosis, selection criteria, age (n=2 variables; baseline, onset or last exam), APOE genotype, availability of autopsy data, Braak stage, and general sociodemographic (race and ethnicity) of participants for whom whole exome sequencing (WXS) data are available.
    9. Case Control Enriched Phenotypes (WES) year 1: prevalent and incident AD status, AD diagnosis, selection criteria, age (n=2 variables; baseline, onset or last exam), APOE genotype, availability of autopsy data, Braak stage, and general sociodemographic (race and ethnicity) of participants for whom whole exome sequencing (WXS) data are available.
pht003394
Beskrivning

pht003394

De-identified Sample ID
Beskrivning

SampleID

Datatyp

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Body site where sample was collected
Beskrivning

BODY_SITE

Datatyp

string

Alias
UMLS CUI [1,1]
C0449705
Analyte Type
Beskrivning

ANALYTE_TYPE

Datatyp

string

Alias
UMLS CUI [1,1]
C4744818
Tumor status
Beskrivning

IS_TUMOR

Datatyp

text

Alias
UMLS CUI [1,1]
C0475752
Center where sample was sequenced
Beskrivning

SEQ_CENTER

Datatyp

string

Alias
UMLS CUI [1,1]
C0000877
UMLS CUI [1,2]
C1294197
UMLS CUI [1,3]
C0370003
Tillbaka till toppen

Similar models

This sample attributes table includes body site where sample was collected, analyte type, tumor status, and sequencing center.

9 Formulär
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table includes subject IDs, consent information, and subject aliases.
    3. This pedigree data table contains family relationships in the format of family IDs, subject IDs, father IDs, mother IDs, subjects's sex, and family group ethnicity.
    4. This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
    5. Family Subject Phenotypes (WGS) year 1: AD affection status, Braak stage, presence of APOE allele combinations, availability of autopsy material, and general sociodemographic (race and ethnicity) data of participants for whom whole genome sequencing (WGS) data are available.
    6. This sample attributes table includes body site where sample was collected, analyte type, tumor status, and sequencing center.
    7. Connecting Family Subject Phenotypes year 1: participants' family members' AD affection status, Braak stage, APOE allele presence, availability of autopsy material, and general sociodemographic data (race and ethnicity).
    8. Case Control Enriched Phenotypes (WES) year 0: prevalent and incident AD status, AD diagnosis, selection criteria, age (n=2 variables; baseline, onset or last exam), APOE genotype, availability of autopsy data, Braak stage, and general sociodemographic (race and ethnicity) of participants for whom whole exome sequencing (WXS) data are available.
    9. Case Control Enriched Phenotypes (WES) year 1: prevalent and incident AD status, AD diagnosis, selection criteria, age (n=2 variables; baseline, onset or last exam), APOE genotype, availability of autopsy data, Braak stage, and general sociodemographic (race and ethnicity) of participants for whom whole exome sequencing (WXS) data are available.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht003394
SampleID
Item
De-identified Sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte Type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
CL Item
Is Tumor (Y)
SEQ_CENTER
Item
Center where sample was sequenced
string
C0000877 (UMLS CUI [1,1])
C1294197 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
Tillbaka till toppen